arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

LB PHARMACEUTICALS INC

LBRX
$47.93 ▼ -0.20 (-0.43%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
3 Visible periods
17 Metrics
Peer-ranked Benchmarks
Price Chart
48
Health
Weak
Neutral
auto_awesome

Analytical Summary

LB PHARMACEUTICALS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $385.6M
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share $-4.38
Trailing P/E
Price / Book 4.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

3-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-25.20M
↑ +60.1%
FCF / Share Free cash flow per share
$-4.38
↑ +97.1%

Health Breakdown

Returns
35
Cash Quality
78

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 3 years · 10 quarters